- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: EGFR Mutation
Total 4265 results
-
Ahon Pharmaceutical Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesUnknown
-
Massachusetts General HospitalYale University; Genentech, Inc.; Stanford University; University of Maryland,...UnknownNon-small Cell Lung CancerUnited States
-
Henan Cancer HospitalUnknownAdvanced NSCLC With EGFR MutationChina
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkUnknown
-
Samsung Medical CenterCompletedMetastatic Breast CancerKorea, Republic of
-
Henan Cancer HospitalUnknownLung AdenocarcinomaChina
-
AstraZenecaCompletedNon-Small Cell Lung CancerRussian Federation
-
Royal Cornwall Hospitals TrustBiocartisCompletedAdenocarcinoma of LungUnited Kingdom
-
Chinese University of Hong KongPamela Youde Nethersole Eastern HospitalCompleted
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal MetastasisChina
-
AstraZenecaCompleted
-
Fuda Cancer Hospital, GuangzhouCompletedLung Neoplasms
-
AbbVieEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedGlioblastomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Singapore, Spain, Switzerland, Taiwan, United Kingdom
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Gene MutationChina
-
Haihe Biopharma Co., Ltd.UnknownNegative T790M Mutation and Met AmplificationChina
-
Boehringer IngelheimCompletedLung NeoplasmsHong Kong, Korea, Republic of, Spain, Singapore, China, United Kingdom, Taiwan, Canada, Australia, Germany, Ireland, Sweden, France, Norway
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell Lung | ErbB ReceptorsUnited States
-
Cancer Institute and Hospital, Chinese Academy...UnknownNon Small Cell Lung Cancer | Stage III Non-small-cell Lung Cancer | EGFR Mutation-Related Tumors
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerItaly, Singapore, Spain, Germany, Korea, Republic of, United States, Belgium, France, Netherlands, Japan
-
Guangdong Association of Clinical TrialsPeking University First Hospital; Zhejiang Cancer Hospital; Peking University... and other collaboratorsUnknownNon-small Cell Lung CancerChina
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell Lung With EGFR Mutation PositiveChina
-
Changi General HospitalCompleted
-
Geneplus-Beijing Co. Ltd.Shanghai Chest HospitalCompletedLung Neoplasms | Adenocarcinoma of Lung | Lung Cancer, Nonsmall Cell | Squamous Cell Lung CancerChina
-
Centre Georges Francois LeclercAstraZenecaTerminatedNon-small Cell Lung Cancer MetastaticFrance
-
Centre Georges Francois LeclercCompletedCarcinoma, Non-Small-Cell LungFrance
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungGermany
-
Allist Pharmaceuticals, Inc.UnknownLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung CancerChina
-
Allist Pharmaceuticals, Inc.Unknown
-
Shenzhen Fifth People's HospitalUnknownNK Cell Mediated ImmunityChina
-
Novartis PharmaceuticalsWithdrawn
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung CarcinomaUnited States, Mexico, Bolivia, Peru, Venezuela
-
Aarhus University HospitalOdense University Hospital; Roche Pharma AG; Herning Hospital; Aalborg University...Unknown
-
AstraZenecaMedpace, Inc.CompletedNon-small Cell Lung CancerUnited States, Canada
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal Metastasis
-
Shanghai Chest HospitalUnknownLung Squamous Cell CarcinomaChina
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Shanghai Chest HospitalCompletedLung Adenocarcinoma | EGFR Activating Mutation
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Non-small Cell Lung CancerChina
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
Konkuk University Medical CenterHanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of
-
Tianjin Medical University Cancer Institute and...UnknownNon Small Cell Lung CancerChina
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungHong Kong, China, Taiwan, Singapore, India
-
ying chengCompletedNon-Small Cell Lung Cancer
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Betta Pharmaceuticals Co., Ltd.CompletedNon-Small Cell Lung CancerChina
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell LungArgentina, Colombia, Uruguay, Chile
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR(+) NSCLC PatientsChina
-
Universität Duisburg-EssenTerminatedNon-small-cell Lung Cancer With Somatic EGFR Mutations
-
The University of Hong KongUnknownNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIBHong Kong